MAP Kinases Pathways in Gastric Cancer.
Animals
Biomarkers
Cell Transformation, Neoplastic
/ genetics
Disease Susceptibility
Epigenesis, Genetic
Helicobacter Infections
/ complications
Helicobacter pylori
Humans
MAP Kinase Signaling System
/ drug effects
MicroRNAs
/ genetics
Mitogen-Activated Protein Kinases
/ metabolism
Neoplasm Metastasis
Neoplasm Staging
RNA, Long Noncoding
/ genetics
Stomach Neoplasms
/ etiology
MAPK
epigenome
gastric cancer
lncRNA
metastasis
miRNA
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
21 Apr 2020
21 Apr 2020
Historique:
received:
18
02
2020
revised:
05
04
2020
accepted:
17
04
2020
entrez:
25
4
2020
pubmed:
25
4
2020
medline:
26
1
2021
Statut:
epublish
Résumé
Gastric cancer (GC) is turning out today to be one of the most important welfare issues for both Asian and European countries. Indeed, while the vast majority of the disease burden is located in China and in Pacific and East Asia, GC in European countries still account for about 100,000 deaths per year. With this review article, we aim to focus the attention on one of the most complex cellular pathways involved in GC proliferation, invasion, migration, and metastasis: the MAP kinases. Such large kinases family is to date constantly studied, since their discovery more than 30 years ago, due to the important role that it plays in the regulation of physiological and pathological processes. Interactions with other cellular proteins as well as miRNAs and lncRNAs may modulate their expression influencing the cellular biological features. Here, we summarize the most important and recent studies involving MAPK in GC. At the same time, we need to underly that, differently from cancers arising from other tissues, where MAPK pathways seems to be a gold target for anticancer therapies, GC seems to be unique in any aspect. Our aim is to review the current knowledge in MAPK pathways alterations leading to GC, including
Identifiants
pubmed: 32326163
pii: ijms21082893
doi: 10.3390/ijms21082893
pmc: PMC7215608
pii:
doi:
Substances chimiques
Biomarkers
0
MicroRNAs
0
RNA, Long Noncoding
0
Mitogen-Activated Protein Kinases
EC 2.7.11.24
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Int J Oncol. 2019 Apr;54(4):1271-1281
pubmed: 30720062
Genome Biol. 2013 Jul 22;14(7):R73
pubmed: 23876380
Science. 1999 Nov 12;286(5443):1358-62
pubmed: 10558990
Int J Oncol. 2019 May;54(5):1545-1554
pubmed: 30864686
Onco Targets Ther. 2018 Aug 07;11:4631-4639
pubmed: 30122954
Cell Host Microbe. 2009 Apr 23;5(4):397-403
pubmed: 19380118
Integr Cancer Ther. 2018 Jun;17(2):511-523
pubmed: 28627240
Life Sci. 2018 Sep 1;208:295-304
pubmed: 30031062
FEBS J. 2012 Sep;279(17):3159-65
pubmed: 22776265
Curr Pharm Des. 2013;19(7):1273-84
pubmed: 23092346
Appl Immunohistochem Mol Morphol. 2019 Aug;27(7):529-534
pubmed: 29734245
Tumour Biol. 2015 Aug;36(8):6053-62
pubmed: 25724188
Clin Cancer Res. 2019 May 15;25(10):3128-3140
pubmed: 30733230
Anticancer Res. 2004 Mar-Apr;24(2B):747-53
pubmed: 15161022
Mol Ther. 2017 Jan 4;25(1):205-217
pubmed: 28129115
Oncotarget. 2016 Jun 21;7(25):38892-38907
pubmed: 26646588
PLoS One. 2019 Jul 26;14(7):e0219865
pubmed: 31348819
Int J Mol Sci. 2019 Jul 31;20(15):
pubmed: 31370155
Int J Cancer. 2014 Feb 15;134(4):822-31
pubmed: 23921907
Med Sci Monit. 2019 Mar 23;25:2141-2150
pubmed: 30902962
Eur J Cancer. 2009 Jul;45(10):1764-72
pubmed: 19251409
J Cell Mol Med. 2020 Jan;24(1):98-113
pubmed: 31691494
Int J Clin Exp Pathol. 2015 Sep 01;8(9):11092-9
pubmed: 26617828
J Cell Mol Med. 2018 Aug;22(8):3875-3886
pubmed: 29761936
Front Cell Infect Microbiol. 2017 Feb 28;7:58
pubmed: 28293545
Oncol Lett. 2018 Sep;16(3):3365-3372
pubmed: 30127936
BMC Cancer. 2010 Jul 12;10:367
pubmed: 20618998
Trends Mol Med. 2007 Sep;13(9):363-72
pubmed: 17822958
Cell Physiol Biochem. 2017;42(6):2364-2376
pubmed: 28848149
J Physiol Biochem. 2011 Mar;67(1):129-39
pubmed: 20981514
Acta Pathol Microbiol Scand. 1965;64:31-49
pubmed: 14320675
Mol Cancer Res. 2008 Mar;6(3):501-8
pubmed: 18337456
Ann N Y Acad Sci. 2020 May;1467(1):94-111
pubmed: 31944316
J Clin Immunol. 2011 Feb;31(1):60-8
pubmed: 20886283
Cancer Manag Res. 2019 Sep 20;11:8589-8602
pubmed: 31572012
Cancer Manag Res. 2019 Jan 11;11:651-667
pubmed: 30666161
Cell Cycle. 2006 May;5(10):1090-3
pubmed: 16721048
Carcinogenesis. 2010 May;31(5):777-84
pubmed: 20080834
Klin Onkol. 2018 Spring;31(2):95-102
pubmed: 29708351
Int J Cancer. 2006 Sep 15;119(6):1217-23
pubmed: 16557568
Gastroenterology. 2015 Oct;149(5):1153-1162.e3
pubmed: 26073375
Am J Transl Res. 2016 Aug 15;8(8):3522-9
pubmed: 27648142
Int J Clin Exp Pathol. 2014 Dec 01;7(12):8471-9
pubmed: 25674211
J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 2):e67-78
pubmed: 18702686
Sci Rep. 2017 Sep 11;7(1):11127
pubmed: 28894280
Medicine (Baltimore). 2018 Feb;97(8):e0036
pubmed: 29465545
Infect Immun. 1997 Aug;65(8):3218-24
pubmed: 9234778
World J Gastroenterol. 2015 Nov 7;21(41):11673-9
pubmed: 26556994
Infect Immun. 2016 Aug 19;84(9):2671-80
pubmed: 27382024
Int J Mol Sci. 2018 Jun 06;19(6):
pubmed: 29882766
Oncotarget. 2016 Aug 9;7(32):52307-52316
pubmed: 27447571
Mol Med Rep. 2014 Oct;10(4):2123-9
pubmed: 25110109
Toxins (Basel). 2018 Apr 19;10(4):
pubmed: 29671784
Oncol Rep. 2012 Apr;27(4):1019-26
pubmed: 22267008
Front Endocrinol (Lausanne). 2018 Aug 03;9:402
pubmed: 30123182
Lancet Oncol. 2008 Feb;9(2):139-48
pubmed: 18207460
PLoS One. 2013 Nov 01;8(11):e77872
pubmed: 24223737
Gene. 2013 Jan 15;513(1):1-13
pubmed: 23123731
Gut. 2012 May;61(5):673-84
pubmed: 22315472
Cell Host Microbe. 2014 Mar 12;15(3):306-16
pubmed: 24629337
Front Oncol. 2018 Oct 26;8:487
pubmed: 30416987
Oncogene. 2007 May 14;26(22):3279-90
pubmed: 17496922
RNA. 2007 Dec;13(12):2287-99
pubmed: 17940140
Oncogene. 2018 May;37(19):2601-2614
pubmed: 29483645
Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):588-597
pubmed: 30720166
Biochem Pharmacol. 2019 Oct;168:285-304
pubmed: 31301277
Oncol Res. 2018 May 7;26(4):581-591
pubmed: 28550678
Oncology. 2009;77(1):12-21
pubmed: 19439999
Cell Res. 2010 Jul;20(7):784-93
pubmed: 20548334
Cell Physiol Biochem. 2017;42(3):999-1012
pubmed: 28683446
Int J Mol Sci. 2019 Mar 21;20(6):
pubmed: 30901834
Eur J Cancer. 2002 Oct;38(15):2048-57
pubmed: 12376211
Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):8852-8860
pubmed: 31696472
BMC Cancer. 2019 May 31;19(1):530
pubmed: 31151422
Cancer Res. 2010 Mar 15;70(6):2339-49
pubmed: 20215506
Cancer Discov. 2019 Mar;9(3):329-341
pubmed: 30770389
Oncotarget. 2017 May 23;8(21):34352-34361
pubmed: 28423721
Cancer Invest. 2014 Jun;32(5):197-205
pubmed: 24669909
Cancer Metastasis Rev. 2019 Sep;38(3):537-548
pubmed: 31486976
J Cell Physiol. 2018 Oct;233(10):6638-6648
pubmed: 29319165
Oncol Lett. 2018 Jun;15(6):8442-8446
pubmed: 29805580
Biochim Biophys Acta. 2016 Jan;1862(1):12-9
pubmed: 26449525
Microbiol Mol Biol Rev. 2011 Mar;75(1):50-83
pubmed: 21372320
Asian Pac J Cancer Prev. 2018 Mar 27;19(3):591-603
pubmed: 29579788
J Gastroenterol Hepatol. 2008 Aug;23(8 Pt 1):1175-81
pubmed: 18637055
Chem Biol Interact. 2020 Jan 25;316:108924
pubmed: 31843629
Mol Cell. 2002 Oct;10(4):745-55
pubmed: 12419219
Biochem Biophys Res Commun. 2019 Oct 29;519(1):113-120
pubmed: 31474334
Cell Physiol Biochem. 2015;37(6):2323-38
pubmed: 26645893
Oncol Rep. 2018 Sep;40(3):1203-1222
pubmed: 29956792
J Biomed Sci. 2018 Sep 11;25(1):68
pubmed: 30205817
Nutrients. 2019 Sep 05;11(9):
pubmed: 31491956
BMC Microbiol. 2012 Jan 17;12:9
pubmed: 22248188
IARC Monogr Eval Carcinog Risks Hum. 1994;61:1-241
pubmed: 7715068
Int J Cancer. 2015 Jan 15;136(2):487-90
pubmed: 24889903
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Tumour Biol. 2016 Apr;37(4):4597-602
pubmed: 26508023
FASEB J. 2019 Mar;33(3):3420-3436
pubmed: 30576232
Oncotarget. 2017 Nov 7;8(68):112530-112549
pubmed: 29348845
Biochem Soc Trans. 2018 Oct 19;46(5):1325-1332
pubmed: 30287508
PLoS One. 2017 Mar 23;12(3):e0174486
pubmed: 28334027
Oncotarget. 2016 Dec 6;7(49):81062-81076
pubmed: 27835600
Oncotarget. 2014 Nov 30;5(22):10976-96
pubmed: 25428918
J Cancer Prev. 2013 Dec;18(4):346-50
pubmed: 25337564
Int J Mol Sci. 2014 Sep 05;15(9):15754-65
pubmed: 25198898
Oncogene. 2004 Aug 5;23(35):5978-85
pubmed: 15184866
Genetics. 2013 Mar;193(3):651-69
pubmed: 23463798
J Gene Med. 2019 Nov;21(11):e3126
pubmed: 31498525
Biomarkers. 2006 Mar-Apr;11(2):184-93
pubmed: 16766394
Onco Targets Ther. 2019 Nov 27;12:10323-10334
pubmed: 31819516
Chin J Cancer. 2010 Jun;29(6):603-10
pubmed: 20507733